Participant cohort (n = 67) | Before 1st vaccine dose | After 2nd vaccine dose | p-value |
---|---|---|---|
Hb (g/dL) | 13.0 \(\pm\) 1.6 | 13.8 \(\pm\) 1.6 | 0.225 |
Hct | 0.42 \(\pm\) 0.04 | 0.42\(\pm\)0.04 | 0.741 |
eGFR (ml/min/1.73m2) | 81.3 \(\pm\)19.5 | 88.0 \(\pm\) 6.6 | 0.203 |
WCC (109/L) | 6.51 \(\pm\)1.49 | 5.98 \(\pm\) 1.65 | 0.003* |
CRP (mg/L) | 0.40 \(\pm\) 0.22 | 0.50 \(\pm\) 0.29 | 0.004* |
LDH (units/L) | 199.8 \(\pm\)39.0 | 205.3 \(\pm\) 53.1 | 0.454 |
Troponin-T (ng/L) | 5 (5–6.2) | 5 (5–5.9) | 0.311 |
NT-pro-BNP (pg/ml) | 35.6 \(\pm\) 23.3 | 31.4 \(\pm\) 27.1 | 0.212 |
6 min walk test (m) | 386.7 \(\pm\) 69.4 | 387.0 \(\pm\) 42.3 | 0.963 |
COVID-19 antibodies present (%) | 0.0 | 82.1 | < 0.001* |